Adverse Events

BESPONSA® offers a well-characterised and manageable safety profile1

Most common (≥20%) adverse reactions:

Please consult the SmPC for more information about Safety.

Reference

  1. BESPONSA® SmPC Summary of Marketing Product Characteristics

PP-INO-GBR-0307. June 2020

BESPONSA® offers a well-characterised and manageable safety profile1

Most common (≥2%) serious adverse reactions (Grade ≥3):

  • Infection (23%)
  • Febrile neutropenia (11%)
  • Haemorrhage (5%)
  • Abdominal pain (3%)
  • Pyrexia (3%)
  • VOD/SOS (2%)
  • Fatigue (2%)

Please consult the SmPC for more information about Safety.

 

SOS, sinusoidal obstruction syndrome; VOD, veno-occlusive disease.

References

  1. BESPONSA® SmPC Summary of Marketing Product Characteristics

PP-INO-GBR-0307. June 2020